InspireMD, Inc. (NSPR) stock
NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3050% below fair value
$0.62−0.07 (-9.50%)
Close on Nov 19, 2026Market cap $28.85MP/E –Yield –
InspireMD gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
InspireMD's gross profit for the twelve months ending Jun 30, 2026 was $1.96M, up 31.5% year over year. For fiscal 2025 it was $2.65M, up 75.9% from the year before. The highest annual figure on record is $2.65M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.65M | +75.9% |
| FY2024 | Dec 31, 2024 | $1.51M | -16.7% |
| FY2023 | Dec 31, 2023 | $1.81M | +61.8% |
| FY2022 | Dec 31, 2022 | $1.12M | +48.1% |
| FY2021 | Dec 31, 2021 | $754.00K | +808.4% |
| FY2020 | Dec 31, 2020 | $83.00K | -89.0% |
| FY2019 | Dec 31, 2019 | $756.00K | -24.0% |
| FY2018 | Dec 31, 2018 | $995.00K | +70.1% |
| FY2017 | Dec 31, 2017 | $585.00K | +473.5% |
| FY2016 | Dec 31, 2016 | $102.00K | – |
| FY2015 | Dec 31, 2015 | -$296.00K | -111.4% |
| FY2013 | Jun 30, 2013 | $2.59M | +15.0% |
| FY2010 | Dec 31, 2010 | $2.25M | +101.2% |
| FY2009 | Dec 31, 2009 | $1.12M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$774.00K | -347.3% |
| Q1 FY2026 | Mar 31, 2026 | $687.00K | +135.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.18M | +151.6% |
| Q3 FY2025 | Sep 30, 2025 | $864.00K | +108.7% |
| Q2 FY2025 | Jun 30, 2025 | $313.00K | -5.4% |
| Q1 FY2025 | Mar 31, 2025 | $292.00K | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | $469.00K | -7.1% |
| Q3 FY2024 | Sep 30, 2024 | $414.00K | -5.5% |
| Q2 FY2024 | Jun 30, 2024 | $331.00K | -32.6% |
| Q1 FY2024 | Mar 31, 2024 | $292.00K | -21.7% |
| Q4 FY2023 | Dec 31, 2023 | $505.00K | +155.1% |
| Q3 FY2023 | Sep 30, 2023 | $438.00K | +19.7% |
| Q2 FY2023 | Jun 30, 2023 | $491.00K | +13.9% |
| Q1 FY2023 | Mar 31, 2023 | $373.00K | +205.7% |
| Q4 FY2022 | Dec 31, 2022 | $198.00K | -32.7% |
| Q3 FY2022 | Sep 30, 2022 | $366.00K | +297.8% |
| Q2 FY2022 | Jun 30, 2022 | $431.00K | +64.5% |
| Q1 FY2022 | Mar 31, 2022 | $122.00K | +15.1% |
| Q4 FY2021 | Dec 31, 2021 | $294.00K | – |
| Q3 FY2021 | Sep 30, 2021 | $92.00K | -69.1% |
| Q2 FY2021 | Jun 30, 2021 | $262.00K | – |
| Q1 FY2021 | Mar 31, 2021 | $106.00K | -64.1% |
| Q4 FY2020 | Dec 31, 2020 | -$390.00K | -250.6% |
| Q3 FY2020 | Sep 30, 2020 | $298.00K | +132.8% |
| Q2 FY2020 | Jun 30, 2020 | -$120.00K | -127.1% |
| Q1 FY2020 | Mar 31, 2020 | $295.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $259.00K | +14.1% |
| Q3 FY2019 | Sep 30, 2019 | $128.00K | -35.4% |
| Q2 FY2019 | Jun 30, 2019 | $442.00K | +59.6% |
| Q1 FY2019 | Mar 31, 2019 | -$73.00K | -124.9% |
| Q4 FY2018 | Dec 31, 2018 | $227.00K | +7.6% |
| Q3 FY2018 | Sep 30, 2018 | $198.00K | +29.4% |
| Q2 FY2018 | Jun 30, 2018 | $277.00K | +88.4% |
| Q1 FY2018 | Mar 31, 2018 | $293.00K | +295.9% |
| Q4 FY2017 | Dec 31, 2017 | $211.00K | – |
| Q3 FY2017 | Sep 30, 2017 | $153.00K | +410.0% |
| Q2 FY2017 | Jun 30, 2017 | $147.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $74.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$56.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $30.00K | – |
See a number that looks wrong?